Eprex and Soliris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eprex (epoetin alfa) and Soliris (eculizumab). Common drug interactions include blood pressure increased among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Eprex and Soliris. It is created by eHealthMe based on reports of 96 people who take the same drugs from the FDA, and is updated regularly.

What is Eprex?

Eprex has active ingredients of epoetin alfa. eHealthMe is studying from 5,554 Eprex users. Check the latest studies of Eprex.

What is Soliris?

Soliris has active ingredients of eculizumab. It is often used in paroxysmal nocturnal hemoglobinuria (pnh). eHealthMe is studying from 58,821 Soliris users. Check the latest studies of Soliris.



On Jul, 18, 2026

96 people who take Eprex and Soliris together, and have interactions are studied.

Eprex and Soliris drug interactions.

What are the common drug interactions of Eprex and Soliris, by gender? *:

female:

  1. Blood pressure increased
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Dyspnoea exertional (breathlessness or shortness of breath)
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Lethargy (tiredness)
  6. Pyrexia (fever)
  7. Asthenia (weakness)
  8. Haemorrhage (bleeding)
  9. Dizziness
  10. Platelet count decreased

male:

  1. Fatigue (feeling of tiredness)
  2. Haemoglobin decreased
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Arthralgia (joint pain)
  5. Pain in extremity
  6. Vomiting
  7. Blood iron increased
  8. Influenza like illness
  9. Night sweats (sweating in night)
  10. Pain

What are the common drug interactions of Eprex and Soliris, by age (0-1 to 60+)? *:

0-1:

  1. Chronic kidney disease
  2. Hypertension (high blood pressure)
  3. Infection

2-9:

  1. Candidiasis (candidiasis or thrush is a fungal infection)
  2. Device related infection
  3. Hypertension (high blood pressure)
  4. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  5. Pulmonary hypertension (increase in blood pressure in the lung artery)

10-19:

n/a

20-29:

  1. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  2. Pneumonia

30-39:

  1. Arthralgia (joint pain)
  2. Pain in extremity
  3. Vomiting
  4. Dizziness
  5. Back pain
  6. Nephrolithiasis (calculi in the kidneys)
  7. Balance disorder
  8. Blood pressure fluctuation
  9. Blood pressure increased
  10. Cough

40-49:

n/a

50-59:

  1. Dyspnoea exertional (breathlessness or shortness of breath)
  2. Fatigue (feeling of tiredness)
  3. Haemoglobin decreased
  4. Influenza like illness
  5. Lethargy (tiredness)
  6. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  7. Nasopharyngitis (inflammation of the nasopharynx)
  8. Night sweats (sweating in night)
  9. Pain
  10. Pain in extremity

60+:

  1. Fatigue (feeling of tiredness)
  2. Dyspnoea (difficult or laboured respiration)
  3. Back pain
  4. Cough
  5. Lower respiratory tract infection
  6. Anaemia (lack of blood)
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Platelet count decreased
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Oropharyngeal pain

What are the existing conditions these people have? *

  1. Anaemia (lack of blood): 48 people, 50.00%
  2. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 36 people, 37.50%
  3. High Blood Pressure: 11 people, 11.46%
  4. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 7 people, 7.29%
  5. Pain: 5 people, 5.21%

* Approximation only. Some reports may have incomplete information.

Do you take Eprex and Soliris?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Eprex and Soliris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Eprex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Soliris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eprex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Soliris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on epoetin alfa and eculizumab (the active ingredients of Eprex and Soliris, respectively), and Eprex and Soliris (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: